These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study. Hreinsson JP; Wong RKM; Tack J; Whorwell P; Benninga MA; Andresen V; Bonaz B; Choi SC; Corazziari ES; Santos J; Fukudo S; Kanazawa M; Fang X; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M Neurogastroenterol Motil; 2023 Jun; 35(6):e14566. PubMed ID: 36961016 [TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: An internet-based survey. Nakov R; Dimitrova-Yurukova D; Snegarova V; Nakov V; Fox M; Heinrich H Neurogastroenterol Motil; 2022 Feb; 34(2):e14197. PubMed ID: 34145679 [TBL] [Abstract][Full Text] [Related]
5. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life. Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391 [TBL] [Abstract][Full Text] [Related]
6. Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education. Simons J; Shajee U; Palsson O; Simren M; Sperber AD; Törnblom H; Whitehead W; Aziz I United European Gastroenterol J; 2022 Sep; 10(7):736-744. PubMed ID: 35781806 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and impact of disorders of Gut-Brain interaction in Sweden. Tornkvist NT; Simrén M; Hreinsson JP; Tack J; Bangdiwala SI; Sperber AD; Palsson OS; Josefsson A; Törnblom H Neurogastroenterol Motil; 2023 Jun; 35(6):e14578. PubMed ID: 37018426 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology and psychological comorbidity of disorders of gut-brain interaction in Australia: Results from the Rome Foundation Global Epidemiology Study. Knowles SR; Apputhurai P; Palsson OS; Bangdiwala S; Sperber AD; Mikocka-Walus A Neurogastroenterol Motil; 2023 Jun; 35(6):e14594. PubMed ID: 37052411 [TBL] [Abstract][Full Text] [Related]
10. The aging gut: Symptoms compatible with disorders of gut-brain interaction (DGBI) in older adults in the general population. Busby-Whitehead J; Whitehead WE; Sperber AD; Palsson OS; Simrén M J Am Geriatr Soc; 2024 Feb; 72(2):479-489. PubMed ID: 37945291 [TBL] [Abstract][Full Text] [Related]
11. The COVID-19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta-analysis. Kulin D; Shah A; Fairlie T; Wong RK; Fang X; Ghoshal UC; Kashyap PC; Mulak A; Lee YY; Talley NJ; Koloski N; Jones MP; Holtmann GJ Neurogastroenterol Motil; 2024 Oct; 36(10):e14878. PubMed ID: 39056447 [TBL] [Abstract][Full Text] [Related]
12. Symptom profiles compatible with disorders of gut-brain interaction (DGBI) in organic gastrointestinal diseases: A global population-based study. van Gils T; Hreinsson JP; Törnblom H; Tack J; Bangdiwala SI; Palsson OS; Sperber AD; Simrén M United European Gastroenterol J; 2024 Sep; 12(7):834-847. PubMed ID: 38975964 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal functioning and menstrual cycle phase in emerging young adult women: a cross-sectional study. Mendelson S; Anbukkarasu P; Cassisi JE; Zaman W BMC Gastroenterol; 2023 Nov; 23(1):406. PubMed ID: 37990300 [TBL] [Abstract][Full Text] [Related]
14. Global prevalence and burden of meal-related abdominal pain. Colomier E; Melchior C; Algera JP; Hreinsson JP; Störsrud S; Törnblom H; Van Oudenhove L; Palsson OS; Bangdiwala SI; Sperber AD; Tack J; Simrén M BMC Med; 2022 Feb; 20(1):71. PubMed ID: 35172840 [TBL] [Abstract][Full Text] [Related]
15. Persistent and newly developed gastrointestinal symptoms after surgery for intestinal malrotation in children: Dysmotility or disorders of gut and brain interaction? Patel D; Banks D; Hira B; Ford M; Ambartsumyan L; Rodriguez L J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):827-835. PubMed ID: 38451033 [TBL] [Abstract][Full Text] [Related]
16. Work productivity and activity impairment in disorders of gut-brain interaction: Data from the Rome Foundation Global Epidemiology Study. Frändemark Å; Törnblom H; Hreinsson JP; Andresen V; Benninga MA; Corazziari ES; Fukudo S; Mulak A; Santos J; Sperber AD; Bangdiwala SI; Palsson OS; Simrén M United European Gastroenterol J; 2023 Jul; 11(6):503-513. PubMed ID: 37332146 [TBL] [Abstract][Full Text] [Related]
17. Pain is a cardinal symptom cutting across Rome IV anatomical categories in disorders of gut-brain interaction: A network-based approach. Burton-Murray H; Guadagnoli L; Vanzhula IA; Brown TA; Sperber AD; Palsson O; Bangdiwala SI; Van Oudenhove L; Staller K Neurogastroenterol Motil; 2024 Oct; 36(10):e14877. PubMed ID: 39077969 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study. Ashktorab H; Challa SR; Singh G; Nanduri S; Ibrahim M; Martirosyan Z; Whitsell P; Chirumamilla LG; Shayegh N; Watson K; Smith T; Ogwo V; Kolawole O; Littleton M; Morrison N; Nair V; Byer D; Dawodu DO; Lexima P; Rashid M; Deverapalli M; Atluri SM; Nezamloo A; Nasrin F; Kim RJ; Sherif Z; Oskrochi G; Carethers JM; Brim H Dig Dis Sci; 2024 Feb; 69(2):562-569. PubMed ID: 38135813 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study. Schmulson MJ; Puentes-Leal GA; Bustos-Fernández L; Francisconi C; Hani A; López-Colombo A; Palsson OS; Bangdiwala SI; Sperber AD Neurogastroenterol Motil; 2023 Jun; 35(6):e14569. PubMed ID: 36989176 [TBL] [Abstract][Full Text] [Related]
20. Worldwide population prevalence and impact of sub-diagnostic gastrointestinal symptoms. Palsson OS; Tack J; Drossman DA; Le Nevé B; Quinquis L; Hassouna R; Ruddy J; Morris CB; Sperber AD; Bangdiwala SI; Simrén M Aliment Pharmacol Ther; 2024 Apr; 59(7):852-864. PubMed ID: 38311841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]